• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effectiveness and hazards of case finding for a high cholesterol concentration.高胆固醇浓度病例筛查的有效性与风险
BMJ. 1990 Jun 16;300(6739):1545-7. doi: 10.1136/bmj.300.6739.1545.
2
Hyperlipidaemia management after primary coronary artery bypass surgery: a survey of patients and general practitioners.冠状动脉搭桥术后高脂血症的管理:一项针对患者和全科医生的调查
J Cardiovasc Risk. 1999 Aug;6(4):263-7. doi: 10.1177/204748739900600412.
3
Selective screening for high cholesterol in Australian general practice: the Newcastle Cholesterol Prediction Study.澳大利亚全科医疗中高胆固醇的选择性筛查:纽卡斯尔胆固醇预测研究。
J Gen Intern Med. 1990 Jan-Feb;5(1):1-8. doi: 10.1007/BF02602300.
4
Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. Imperial Cancer Research Fund OXCHECK Study Group.OXCHECK试验中心脏病危险因素的患病率:对初级保健筛查的意义。帝国癌症研究基金会OXCHECK研究小组。
BMJ. 1991 May 4;302(6784):1057-60. doi: 10.1136/bmj.302.6784.1057.
5
Effectiveness of programme for reducing cardiovascular risk for men in one general practice.一项全科医疗中降低男性心血管疾病风险项目的成效
BMJ. 1993 Jun 19;306(6893):1652-6. doi: 10.1136/bmj.306.6893.1652.
6
Women and men with hypercholesterolemia respond similarly to an American Heart Association step 1 diet.患有高胆固醇血症的女性和男性对美国心脏协会第一步饮食计划的反应相似。
J Am Diet Assoc. 1995 Apr;95(4):436-41. doi: 10.1016/S0002-8223(95)00118-2.
7
Observed changes in the lipid profile and calculated coronary risk in patients given dietary advice in primary care.在初级保健中接受饮食建议的患者的血脂谱变化及计算得出的冠心病风险。
Br J Gen Pract. 2000 Sep;50(458):712-5.
8
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial.降血压饮食对血脂的影响:终止高血压膳食方法(DASH)试验
Am J Clin Nutr. 2001 Jul;74(1):80-9. doi: 10.1093/ajcn/74.1.80.
9
The awareness of the risk of elevated cholesterol levels and knowledge about cholesterol-lowering action in Australia.澳大利亚民众对胆固醇水平升高风险的认知以及对降胆固醇措施的了解。
Med J Aust. 1990 Jan 15;152(2):72-5. doi: 10.5694/j.1326-5377.1990.tb124458.x.
10
Community-based cholesterol screening and education to prevent heart disease: five-year results of the North Coast Cholesterol Check Campaign.基于社区的胆固醇筛查与教育预防心脏病:北海岸胆固醇检查运动的五年成果
Aust J Public Health. 1993 Jun;17(2):109-16. doi: 10.1111/j.1753-6405.1993.tb00117.x.

引用本文的文献

1
Role of C-reactive protein when prescribing a statin.当开具他汀类药物时 C-反应蛋白的作用。
Curr Atheroscler Rep. 2012 Feb;14(1):26-32. doi: 10.1007/s11883-011-0218-8.
2
Randomised controlled trial of the effects of physical activity feedback on awareness and behaviour in UK adults: the FAB study protocol [ISRCTN92551397].英国成年人身体活动反馈对意识和行为影响的随机对照试验:FAB 研究方案[ISRCTN92551397]。
BMC Public Health. 2010 Mar 18;10(1):144. doi: 10.1186/1471-2458-10-144.
3
Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.糖尿病筛查结果为阴性的人是否会得到错误的安心?嵌入ADDITION(剑桥)随机对照试验的平行组队列研究。
BMJ. 2009 Nov 30;339:b4535. doi: 10.1136/bmj.b4535.
4
Cholesterol and coronary heart disease: screening and treatment.胆固醇与冠心病:筛查与治疗
Qual Health Care. 1998 Dec;7(4):232-9. doi: 10.1136/qshc.7.4.232.
5
Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence.全科医疗中胆固醇相关干预措施的经济学评估。证据评估。
J Epidemiol Community Health. 1998 Sep;52(9):586-94. doi: 10.1136/jech.52.9.586.
6
The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group.初级保健中心血管筛查与干预的心理影响:虚假安慰问题?英国家庭心脏研究小组
Br J Gen Pract. 1996 Oct;46(411):577-82.
7
Cost effectiveness of lowering cholesterol. Study did not take account of confounders.降低胆固醇的成本效益。该研究未考虑混杂因素。
BMJ. 1996 Nov 2;313(7065):1142-3; author reply 1144. doi: 10.1136/bmj.313.7065.1142b.
8
Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration.在英格兰北部进行的一项关于个人知晓自身血清胆固醇浓度影响的随机对照试验。
J Epidemiol Community Health. 1994 Feb;48(1):22-5. doi: 10.1136/jech.48.1.22.
9
Population screening for genetic susceptibility to disease.针对疾病遗传易感性的人群筛查。
BMJ. 1995 Jul 1;311(6996):35-8. doi: 10.1136/bmj.311.6996.35.
10
Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?降低血清胆固醇浓度的增量项目的成本效益:个体干预是否值得?
BMJ. 1991 May 11;302(6785):1119-22. doi: 10.1136/bmj.302.6785.1119.

本文引用的文献

1
Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study.血浆胆固醇和甘油三酯的再测信度。脂质研究临床患病率研究。
Am J Epidemiol. 1982 Dec;116(6):878-85. doi: 10.1093/oxfordjournals.aje.a113490.
2
Sick individuals and sick populations.患病个体与患病群体。
Int J Epidemiol. 1985 Mar;14(1):32-8. doi: 10.1093/ije/14.1.32.
3
Population screening for cholesterol determination. A pilot study.
JAMA. 1986 Nov 28;256(20):2839-42.
4
Effect of screening and referral on follow-up and treatment of high blood cholesterol levels.筛查与转诊对高胆固醇水平随访及治疗的影响。
Am J Prev Med. 1988 Sep-Oct;4(5):244-8.
5
Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.血清胆固醇、血压与死亡率:来自361,662名男性队列研究的启示
Lancet. 1986 Oct 25;2(8513):933-6. doi: 10.1016/s0140-6736(86)90597-0.
6
Reducing the risks of coronary heart disease in individuals and in the population.降低个体及人群中冠心病的风险。
Lancet. 1986 Apr 26;1(8487):956-9. doi: 10.1016/s0140-6736(86)91054-8.
7
Selective screening for high cholesterol in Australian general practice: the Newcastle Cholesterol Prediction Study.澳大利亚全科医疗中高胆固醇的选择性筛查:纽卡斯尔胆固醇预测研究。
J Gen Intern Med. 1990 Jan-Feb;5(1):1-8. doi: 10.1007/BF02602300.

高胆固醇浓度病例筛查的有效性与风险

Effectiveness and hazards of case finding for a high cholesterol concentration.

作者信息

Kinlay S, Heller R F

机构信息

Centre for Clinical Epidemiology and Biostatistics, Faculty of Medicine, University of Newcastle, Australia.

出版信息

BMJ. 1990 Jun 16;300(6739):1545-7. doi: 10.1136/bmj.300.6739.1545.

DOI:10.1136/bmj.300.6739.1545
PMID:2372619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1663079/
Abstract

OBJECTIVE

To see whether adults with high blood cholesterol concentrations (greater than 6.5 mmol/l) detected by case finding return to their doctor, receive appropriate advice, and report changes in their diet and whether adults found not to have high cholesterol concentrations on case finding are discouraged from changing their diet.

DESIGN

Follow up study.

SETTING

Seven general practices in the lower Hunter region of Australia.

PARTICIPANTS

600 Men and women aged 25-65 who had their blood cholesterol concentrations measured three to four months earlier while attending their general practitioner. Analysis conducted on 552 (92%) who returned follow up postal questionnaires.

MEASUREMENTS AND MAIN RESULTS

Of the 125 subjects found to have blood cholesterol concentrations greater than 6.5 mmol/l, 102 (82%) returned to their doctor and 83 of these recalled receiving dietary advice. 93 (75%) Subjects with high concentrations reported changing their diet compared with 72 (46%) subjects with concentrations of greater than 5.5-6.5 mmol/l and 44 (17%) subjects with lower concentrations. Overall 333 (61%) of all respondents who answered reported not changing their diet, the most common reason (nearly half the sample; n = 266) being that their cholesterol concentration was "all right." Adults without high cholesterol concentrations who returned to their doctor were also significantly more likely to recall their doctor saying that they did not need to lower their concentrations (less than or equal to 5.5 mmol/l = 61%; greater than 5.5-6.5 mmol/l = 12%; greater than 6.5 mmol/l = 5%) and significantly less likely to recall receiving dietary advice (less than or equal to 5.5 mmol/l = 13%; greater than 5.5-6.5 mmol/l = 60%; greater than 6.5 mmol/l = 82%).

CONCLUSIONS

High risk strategies which require everyone to be tested for high cholesterol concentrations may interfere with population strategies designed to reduce everyone's dietary intake of fat.

摘要

目的

了解通过病例筛查发现血胆固醇浓度高(大于6.5 mmol/l)的成年人是否会回访医生、接受适当建议并报告其饮食变化,以及通过病例筛查发现血胆固醇浓度不高的成年人是否会被劝阻改变饮食。

设计

随访研究。

地点

澳大利亚猎人谷下游地区的7家普通诊所。

参与者

600名年龄在25 - 65岁之间的男性和女性,他们在看全科医生时于三到四个月前测量了血胆固醇浓度。对552名(92%)返回随访邮寄问卷的参与者进行了分析。

测量指标及主要结果

在125名被发现血胆固醇浓度大于6.5 mmol/l的受试者中,102名(82%)回访了医生,其中83名回忆起接受了饮食建议。93名(75%)高浓度受试者报告改变了饮食,而浓度大于5.5 - 6.5 mmol/l的受试者中有72名(46%),低浓度受试者中有44名(17%)报告改变了饮食。总体而言,所有回答问卷的受访者中有333名(61%)报告未改变饮食,最常见的原因(近一半样本;n = 266)是他们的胆固醇浓度“正常”。回访医生的血胆固醇浓度不高的成年人也更有可能回忆起医生说他们无需降低胆固醇浓度(小于或等于5.5 mmol/l = 61%;大于5.5 - 6.5 mmol/l = 12%;大于6.5 mmol/l = 5%),且明显不太可能回忆起接受过饮食建议(小于或等于5.5 mmol/l = 13%;大于5.5 - 6.5 mmol/l = 60%;大于6.5 mmol/l = 82%)。

结论

要求对每个人进行高胆固醇浓度检测的高风险策略可能会干扰旨在减少每个人脂肪饮食摄入量的人群策略。